NASDAQ:ENTX

Entera Bio Stock Insider Trading

Healthcare > Biotechnology

Buy ENTX

*Your capital is at risk

$1.22

-0.0300 (-2.40%)

At Close: Jun 03, 2026

Entera Bio Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 8.52M and sold 0 ENTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	8.52M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Oct 02, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Taitel Haya Director	Director	7 278 Value: $13.5K
Aug 27, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Ostrov Gerald M Director	Director	20 446 Value: $35.2K
Aug 27, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Malca Yonatan Director	Director	23 172 Value: $39.9K
Aug 27, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Ostrov Gerald M Director	Director	20 446 Value: $35.2K
Aug 27, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Taitel Haya Director	Director	15 335 Value: $26.4K
Aug 27, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Ellis Sean Director	Director	18 061 Value: $31.1K
Aug 27, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Malca Yonatan Director	Director	23 172 Value: $39.9K
Aug 27, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Lieberman Gerald M Director	Director	27 261 Value: $46.9K
Aug 27, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Ellis Sean Director	Director	18 061 Value: $31.1K
Aug 27, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Taitel Haya Director	Director	15 335 Value: $26.4K
Aug 27, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Lieberman Gerald M Director	Director	27 261 Value: $46.9K
Jul 31, 2024 Buy	Stock Option (Right to Buy) A-Award	Toledano Miranda Jayne Chief Executive Officer	CEO / President	500 000 Value: $995.0K
Jul 31, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Toledano Miranda Jayne Chief Executive Officer	CEO / President	124 121 Value: $199.8K
Jul 31, 2024 Buy	Stock Option (Right to Buy) A-Award	Toledano Miranda Jayne Chief Executive Officer	CEO / President	500 000 Value: $995.0K
Jul 31, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Toledano Miranda Jayne Chief Executive Officer	CEO / President	124 121 Value: $199.8K
May 28, 2024 Buy	Stock Option (right to buy)	Burshtein Gregory Chief Of R&d	Officer	65 000 Value: $51.7K
May 28, 2024 Buy	Stock Option (right to buy)	Burshtein Gregory Chief Of R&d	Officer	150 000 Value: $298.5K
May 28, 2024 Buy	Ordinary Shares, par value NIS 0.0000769 per share	Burshtein Gregory Chief Of R&d	Officer	0 Value: $0
May 28, 2024 Buy	Stock Option (right to buy)	Burshtein Gregory Chief Of R&d	Officer	51 000 Value: $184.1K
May 28, 2024 Buy	Stock Option (right to buy)	Burshtein Gregory Chief Of R&d	Officer	20 000 Value: $79.4K
May 28, 2024 Buy	Stock Option (right to buy)	Burshtein Gregory Chief Of R&d	Officer	18 900 Value: $40.4K
Dec 22, 2023 Buy	Pre-funded warrant	Knoll Capital Management, Llc 10 Percent Owner	10% Owner	347 604 Value: $0
Dec 22, 2023 Buy	Warrants (right to buy)	Knoll Capital Management, Llc 10 Percent Owner	10% Owner	1 197 604 Value: $1.20M
Dec 22, 2023 Buy	Warrants (right to buy)	Knoll Capital Management, Llc 10 Percent Owner	10% Owner	1 197 604 Value: $1.20M
Dec 22, 2023 Buy	Pre-funded warrant	Knoll Capital Management, Llc 10 Percent Owner	10% Owner	347 604 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ENTERA BIO LTD.

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials fo...

Read Full Profile Here